Literature DB >> 29569174

Relationship between Organizational Culture and the Use of Psychotropic Medicines in Nursing Homes: A Systematic Integrative Review.

Mouna Sawan1, Yun-Hee Jeon2, Timothy F Chen3.   

Abstract

BACKGROUND: Psychotropic medicines are commonly used in nursing homes, despite marginal clinical benefits and association with harm in the elderly. Organizational culture is proposed as a factor explaining the high-level use of psychotropic medicines. Schein describes three levels of culture: artifacts, espoused values, and basic assumptions.
OBJECTIVE: This integrative review aimed to investigate the facets and role of organizational culture in the use of psychotropic medicines in nursing homes.
METHOD: Five databases were searched for qualitative, quantitative, and mixed method empirical studies up to 13 February 2017. Articles were included if they examined an aspect of organizational culture according to Schein's theory and the use of psychotropic medicines in nursing homes for the management of behavioral and sleep disturbances in residents. Article screening and data extraction were performed independently by one reviewer and checked by the research team. The integrative review method, an approach similar to the method of constant comparison analysis was utilized for data analysis.
RESULTS: Twenty-four studies met the inclusion criteria: 13 used quantitative methods, 9 used qualitative methods, 1 was quasi-qualitative, and 1 used mixed methods. Included studies were found to only address two aspects of organizational culture in relation to the use of psychotropic medicines: artifacts and espoused values. No studies addressed the basic assumptions, the unsaid taken-for-granted beliefs, which provide explanations for in/consistencies between the ideal use of psychotropic medicines and the actual use of psychotropic medicines.
CONCLUSIONS: Previous studies suggest that organizational culture influences the use of psychotropic medicines in nursing homes; however, what is known is descriptive of culture only at the surface level, that is the artifacts and espoused values. Hence, future research that explains the impact of the basic assumptions of culture on the use of psychotropic medicines is important.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29569174     DOI: 10.1007/s40266-018-0527-5

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  64 in total

1.  Challenges to the use of nonpharmacologic interventions in nursing homes.

Authors:  Marisue Cody; Cornelia Beck; Bonnie L Svarstad
Journal:  Psychiatr Serv       Date:  2002-11       Impact factor: 3.084

2.  Nurse-physician communication and quality of drug use in Swedish nursing homes.

Authors:  Ingrid K Schmidt; Bonnie L Svarstad
Journal:  Soc Sci Med       Date:  2002-06       Impact factor: 4.634

3.  Quality of psychopharmacological medication use in nursing home residents.

Authors:  Linda Simoni-Wastila; Yu-Jung Wei; Mario Luong; Christine Franey; Ting-Ying Huang; Gail B Rattinger; Ilene H Zuckerman; Nicole Brandt; Judith A Lucas
Journal:  Res Social Adm Pharm       Date:  2013-11-15

Review 4.  Management of neuropsychiatric symptoms in people with dementia.

Authors:  Clive Ballard; Anne Corbett
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

5.  Physicians' perceptions of their role in treating dementia-related behavior problems in the nursing home: actual practice and the ideal.

Authors:  Jiska Cohen-Mansfield; Barbara Jensen
Journal:  J Am Med Dir Assoc       Date:  2008-09-07       Impact factor: 4.669

6.  Exploring the link between organizational climate and the use of psychotropic medicines in nursing homes: A qualitative study.

Authors:  Mouna Sawan; Yun-Hee Jeon; Romano A Fois; Timothy F Chen
Journal:  Res Social Adm Pharm       Date:  2016-07-05

7.  Variation in nursing home antipsychotic prescribing rates.

Authors:  Paula A Rochon; Therese A Stukel; Susan E Bronskill; Tara Gomes; Kathy Sykora; Walter P Wodchis; Michael Hillmer; Alexander Kopp; Jerry H Gurwitz; Geoffrey M Anderson
Journal:  Arch Intern Med       Date:  2007-04-09

8.  Assessment of a United States pharmaceutical care model for nursing homes in the United Kingdom.

Authors:  Susan M Patterson; Carmel M Hughes; Kate L Lapane
Journal:  Pharm World Sci       Date:  2007-06-29

Review 9.  Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review.

Authors:  Jo Thompson Coon; Rebecca Abbott; Morwenna Rogers; Rebecca Whear; Stephen Pearson; Iain Lang; Nick Cartmell; Ken Stein
Journal:  J Am Med Dir Assoc       Date:  2014-08-08       Impact factor: 4.669

Review 10.  Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.

Authors:  Dallas P Seitz; Sudeep S Gill; Nathan Herrmann; Sarah Brisbin; Mark J Rapoport; Jenna Rines; Kimberley Wilson; Ken Le Clair; David K Conn
Journal:  Int Psychogeriatr       Date:  2012-10-19       Impact factor: 3.878

View more
  5 in total

1.  Nurses', Pharmacists' and Family Physicians' Perceptions of Psychotropic Medication Monitoring in Australian Long-Term Care Facilities: A Qualitative Framework Analysis.

Authors:  Aili V Langford; Garzee Tracy Ngo; Timothy F Chen; Chris Roberts; Carl R Schneider
Journal:  Drugs Aging       Date:  2020-12-14       Impact factor: 3.923

Review 2.  A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.

Authors:  Mouna Sawan; Emily Reeve; Justin Turner; Adam Todd; Michael A Steinman; Mirko Petrovic; Danijela Gnjidic
Journal:  Expert Rev Clin Pharmacol       Date:  2020-02-27       Impact factor: 5.045

3.  State Variation in Chronic Opioid Use in Long-Term Care Nursing Home Residents.

Authors:  Hemalkumar B Mehta; Yong-Fang Kuo; Mukaila A Raji; Jordan Westra; Cynthia Boyd; G Caleb Alexander; James S Goodwin
Journal:  J Am Med Dir Assoc       Date:  2021-05-19       Impact factor: 4.669

4.  How far are we from a medication use process aiming at well-informed adherent patients with long-term medications in Finland? Qualitative study.

Authors:  Niina Mononen; Marika Pohjanoksa-Mäntylä; Marja Sa Airaksinen; Katri Hämeen-Anttila
Journal:  BMJ Open       Date:  2020-06-21       Impact factor: 2.692

5.  What Makes Deprescription of Psychotropic Drugs in Nursing Home Residents with Dementia so Challenging? A Qualitative Systematic Review of Barriers and Facilitators.

Authors:  Amalie Elisabeth Moth; Pernille Hølmkjær; Anne Holm; Maarten Pieter Rozing; Gritt Overbeck
Journal:  Drugs Aging       Date:  2021-07-07       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.